P.A.W. Capital Corp lifted its holdings in DocGo Inc. (NASDAQ:DCGO – Free Report) by 60.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,200,000 shares of the company’s stock after buying an additional 1,200,000 shares during the period. DocGo makes up 9.7% of P.A.W. Capital Corp’s holdings, making the stock its 3rd biggest position. P.A.W. Capital Corp owned 3.14% of DocGo worth $5,024,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of the business. Bank of New York Mellon Corp boosted its position in shares of DocGo by 8.1% during the 1st quarter. Bank of New York Mellon Corp now owns 365,468 shares of the company’s stock valued at $965,000 after acquiring an additional 27,309 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of DocGo by 546.1% during the first quarter. Victory Capital Management Inc. now owns 372,487 shares of the company’s stock worth $983,000 after purchasing an additional 314,838 shares in the last quarter. Jefferies Financial Group Inc. lifted its holdings in DocGo by 6,874.1% during the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company’s stock worth $5,358,000 after buying an additional 2,000,356 shares in the last quarter. Nuveen LLC acquired a new stake in shares of DocGo in the first quarter valued at $649,000. Finally, Russell Investments Group Ltd. increased its holdings in DocGo by 59.0% during the 1st quarter. Russell Investments Group Ltd. now owns 229,213 shares of the company’s stock worth $605,000 after purchasing an additional 85,097 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.
DocGo Stock Down 3.4%
Shares of NASDAQ:DCGO opened at $0.93 on Wednesday. The company has a market cap of $90.96 million, a price-to-earnings ratio of -1.79 and a beta of 0.93. The firm’s 50-day simple moving average is $1.26 and its 200-day simple moving average is $1.45. DocGo Inc. has a fifty-two week low of $0.92 and a fifty-two week high of $5.68.
Analyst Ratings Changes
DCGO has been the subject of several analyst reports. Canaccord Genuity Group lowered their price target on shares of DocGo from $1.60 to $1.50 and set a “buy” rating for the company in a report on Wednesday, November 12th. Zacks Research upgraded DocGo from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DocGo in a research note on Monday. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $3.21.
Read Our Latest Research Report on DCGO
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
- Five stocks we like better than DocGo
- How to Capture the Benefits of Dividend Increases
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- What to Know About Investing in Penny Stocks
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
